Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision | Next revisionBoth sides next revision | ||
| content:valproate [2020/02/17 11:15] – [Main ADRs] icna | content:valproate [2020/02/17 12:52] – icna | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| ====== Valproate ====== | ====== Valproate ====== | ||
| - | Valproic acid (2-propyl pentanoic acid, 2-propyl valeric acid) is a short-chain branched fatty acid. Prior to the serendipitous discovery of its anti-epileptic activity in 1963, valproic acid was used as an organic solvent. | + | Valproic acid (2-propyl pentanoic acid, 2-propyl valeric acid) is a short-chain branched fatty acid. Prior to the serendipitous discovery of its anti-epileptic activity in 1963, valproic acid was used as an organic solvent[(: |
| ===== Authorised indications ===== | ===== Authorised indications ===== | ||
| UK-SmPC: In the treatment of generalized, | UK-SmPC: In the treatment of generalized, | ||